|
1
|
Wu X, Liu X, Sengupta J, Bu Y, Yi F, Wang
C, Shi Y, Zhu Y, Jiao Q and Song F: Silencing of Bmi-1 gene by RNA
interference enhances sensitivity to doxorubicin in breast cancer
cells. Indian J Exp Biol. 49:105–112. 2011.PubMed/NCBI
|
|
2
|
Sinha BK, Mimnaugh EG, Rajagopalan S and
Myers CE: Adriamycin activation and oxygen free radical formation
in human breast tumor cells: Protective role of glutathione
peroxidase in adriamycin resistance. Cancer Res. 49:3844–3848.
1989.PubMed/NCBI
|
|
3
|
Minotti G, Menna P, Salvatorelli E, Cairo
G and Gianni L: Anthracyclines: Molecular advances and
pharmacologic developments in antitumor activity and
cardiotoxicity. Pharmacol Rev. 56:185–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Jacobson MD, Weil M and Raff MC:
Programmed cell death in animal development. Cell. 88:347–354.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wong RS: Apoptosis in cancer: From
pathogenesis to treatment. J Exp Clin Cancer Res. 30:872011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chipuk JE, Moldoveanu T, Llambi F, Parsons
MJ and Green DR: The BCL-2 family reunion. Mol Cell. 37:299–310.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strobel T, Swanson L, Korsmeyer S and
Cannistra SA: BAX enhances paclitaxel-induced apoptosis through a
p53-independent pathway. Proc Natl Acad Sci USA. 93:14094–14099.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kelly GL and Strasser A: The essential
role of evasion from cell death in cancer. Adv Cancer Res.
111:39–96. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chorna IV, Datsyuk LO and Stoika RS:
Expression of Bax, Bad and Bcl-2 proteins under x-radiation effect
towards human breast carcinoma MCF-7 cells and their
doxorubicin-resistant derivatives. Exp Oncol. 27:196–201.
2005.PubMed/NCBI
|
|
10
|
Lindsay J, Esposti MD and Gilmore AP:
Bcl-2 proteins and mitochondria - specificity in membrane targeting
for death. Biochim Biophys Acta. 1813:532–539. 2011. View Article : Google Scholar
|
|
11
|
Sharifi S, Barar J, Hejazi MS and Samadi
N: Doxorubicin changes Bax/Bcl-xL ratio, caspase-8 and 9 in breast
cancer cells. Adv Pharm Bull. 5:351–359. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wieder T, Essmann F, Prokop A, Schmelz K,
Schulze-Osthoff K, Beyaert R, Dörken B and Daniel PT: Activation of
caspase-8 in drug-induced apoptosis of B-lymphoid cells is
independent of CD95/Fas receptor-ligand interaction and occurs
downstream of caspase-3. Blood. 97:1378–1387. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang S, Zhou Q and Yang X: Caspase-3
status is a determinant of the differential responses to genistein
between MDA-MB-231 and MCF-7 breast cancer cells. Biochim Biophys
Acta. 1773:903–911. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Porter AG and Jänicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kruidering M and Evan GI: Caspase-8 in
apoptosis: The beginning of ‘the end’? IUBMB Life. 50:85–90. 2000.
View Article : Google Scholar
|
|
16
|
Goffart S, von Kleist-Retzow JC and
Wiesner RJ: Regulation of mitochondrial proliferation in the heart:
Power-plant failure contributes to cardiac failure in hypertrophy.
Cardiovasc Res. 64:198–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ridnour LA, Oberley TD and Oberley LW:
Tumor suppressive effects of MnSOD overexpression may involve
imbalance in peroxide generation versus peroxide removal. Antioxid
Redox Signal. 6:501–512. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vera-Ramirez L, Sanchez-Rovira P,
Ramirez-Tortosa MC, Ramirez-Tortosa CL, Granados-Principal S,
Lorente JA and Quiles JL: Free radicals in breast carcinogenesis,
breast cancer progression and cancer stem cells. Biological bases
to develop oxidative-based therapies. Crit Rev Oncol Hematol.
80:347–368. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sosa V, Moliné T, Somoza R, Paciucci R,
Kondoh H and Leonart ME: Oxidative stress and cancer: An overview.
Ageing Res Rev. 12:376–390. 2013. View Article : Google Scholar
|
|
20
|
Miao L and St Clair DK: Regulation of
superoxide dismutase genes: Implications in disease. Free Radic
Biol Med. 47:344–356. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kamarajugadda S, Cai Q, Chen H, Nayak S,
Zhu J, He M, Jin Y, Zhang Y, Ai L, Martin SS, et al: Manganese
superoxide dismutase promotes anoikis resistance and tumor
metastasis. Cell Death Dis. 4:e5042013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kattan Z, Minig V, Leroy P, Dauça M and
Becuwe P: Role of manganese superoxide dismutase on growth and
invasive properties of human estrogen-independent breast cancer
cells. Breast Cancer Res Treat. 108:203–215. 2008. View Article : Google Scholar
|
|
23
|
Kiningham KK, Cardozo ZA, Cook C, Cole MP,
Stewart JC, Tassone M, Coleman MC and Spitz DR: All-trans-retinoic
acid induces manganese superoxide dismutase in human neuroblastoma
through NF-kappaB. Free Radic Biol Med. 44:1610–1616. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen PM, Wu TC, Wang YC, Cheng YW, Sheu
GT, Chen CY and Lee H: Activation of NF-κB by SOD2 promotes the
aggressiveness of lung adenocarcinoma by modulating NKX2–1-mediated
IKKβ expression. Carcinogenesis. 34:2655–2663. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mantovani A: Molecular pathways linking
inflammation and cancer. Curr Mol Med. 10:369–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fisher DE: Apoptosis in cancer therapy:
Crossing the threshold. Cell. 78:539–542. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lukyanova NY, Rusetskya NV, Tregubova NA
and Chekhun VF: Molecular profile and cell cycle in MCF-7 cells
resistant to cisplatin and doxorubicin. Exp Oncol. 31:87–91.
2009.PubMed/NCBI
|
|
28
|
Taherian A and Mazoochi T: Different
expression of extracellular signal-regulated kinases (ERK) 1/2 and
phospho-Erk proteins in MBA-MB-231 and MCF-7 cells after
chemotherapy with doxorubicin or docetaxel. Iran J Basic Med Sci.
15:669–677. 2012.PubMed/NCBI
|
|
29
|
Fornari FA, Randolph JK, Yalowich JC,
Ritke MK and Gewirtz DA: Interference by doxorubicin with DNA
unwinding in MCF-7 breast tumor cells. Mol Pharmacol. 45:649–656.
1994.PubMed/NCBI
|
|
30
|
Schneiderman RS, Shmueli E, Kirson ED and
Palti Y: TTFields alone and in combination with chemotherapeutic
agents effectively reduce the viability of MDR cell sub-lines that
over-express ABC transporters. BMC Cancer. 10:2292010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gupta P and Srivastava SK: Antitumor
activity of phenethyl isothiocyanate in HER2-positive breast cancer
models. BMC Med. 10:802012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Mahéo K, Vibet S, Steghens JP, Dartigeas
C, Lehman M, Bougnoux P and Goré J: Differential sensitization of
cancer cells to doxorubicin by DHA: A role for lipoperoxidation.
Free Radic Biol Med. 39:742–751. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tudor G, Aguilera A, Halverson DO, Laing
ND and Sausville EA: Susceptibility to drug-induced apoptosis
correlates with differential modulation of Bad, Bcl-2 and Bcl-xL
protein levels. Cell Death Differ. 7:574–586. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Varfolomeev EE, Schuchmann M, Luria V,
Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM,
Kemper OC, Kollet O, et al: Targeted disruption of the mouse
caspase 8 gene ablates cell death induction by the TNF receptors,
Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 9:267–276.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wesselborg S, Engels IH, Rossmann E, Los M
and Schulze-Osthoff K: Anticancer drugs induce caspase-8/FLICE
activation and apoptosis in the absence of CD95 receptor/ligand
interaction. Blood. 93:3053–3063. 1999.PubMed/NCBI
|
|
37
|
Liu WH and Chang LS: Fas/FasL-dependent
and -independent activation of caspase-8 in doxorubicin-treated
human breast cancer MCF-7 cells: ADAM10 down-regulation activates
Fas/FasL signaling pathway. Int J Biochem Cell Biol Dec.
43:1708–1719. 2011. View Article : Google Scholar
|
|
38
|
Hu Y, Benedict MA, Wu D, Inohara N and
Núñez G: Bcl-XL interacts with Apaf-1 and inhibits Apaf-1-dependent
caspase-9 activation. Proc Natl Acad Sci USA. 95:4386–4391. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liang Y, Yan C and Schor NF: Apoptosis in
the absence of Caspase 3. Oncogene. 20:6570–6578. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cheah YH, Nordin FJ, Tee TT, Azimahtol HL,
Abdullah NR and Ismail Z: Antiproliferative property and apoptotic
effect of xanthorrhizol on MDA-MB-231 breast cancer cells.
Anticancer Res. 28(6A): 3677–3689. 2008.
|
|
41
|
Cui Q, Yu JH, Wu JN, Tashiro S, Onodera S,
Minami M and Ikejima T: P53-mediated cell cycle arrest and
apoptosis through a caspase-3-independent, but caspase-9-dependent
pathway in oridonin-treated MCF-7 human breast cancer cells. Acta
Pharmacol Sin. 28:1057–1066. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang HL, Chen CS, Chang WH, Lu FJ, Lai YC,
Chen CC, Hseu TH, Kuo CT and Hseu YC: Growth inhibition and
induction of apoptosis in MCF-7 breast cancer cells by Antrodia
camphorata. Cancer Lett. 231:215–227. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen JS, Konopleva M, Andreeff M, Multani
AS, Pathak S and Mehta K: Drug-resistant breast carcinoma (MCF-7)
cells are paradoxically sensitive to apoptosis. J Cell Physiol.
200:223–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
McGee MM, Hyland E, Campiani G, Ramunno A,
Nacci V and Zisterer DM: Caspase-3 is not essential for DNA
fragmentation in MCF-7 cells during apoptosis induced by the
pyrrolo-1,5-benzoxazepine, PBOX-6. FEBS Lett. 515:66–70. 2002.
View Article : Google Scholar
|
|
45
|
Zhang Y, Zhang HM, Shi Y, Lustgarten M, Li
Y, Qi W, Zhang BX and Van Remmen H: Loss of manganese superoxide
dismutase leads to abnormal growth and signal transduction in mouse
embryonic fibroblasts. Free Radic Biol Med. 49:1255–1262. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cerutti P, Ghosh R, Oya Y and Amstad P:
The role of the cellular antioxidant defense in oxidant
carcinogenesis. Environ Health Perspect. 102(Suppl 10): 123–129.
1994. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Behrend L, Henderson G and Zwacka RM:
Reactive oxygen species in oncogenic transformation. Biochem Soc
Trans. 31:1441–1444. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chua PJ, Yip GW and Bay BH: Cell cycle
arrest induced by hydrogen peroxide is associated with modulation
of oxidative stress related genes in breast cancer cells. Exp Biol
Med (Maywood). 234:1086–1094. 2009. View Article : Google Scholar
|
|
49
|
Takada Y, Mukhopadhyay A, Kundu GC,
Mahabeleshwar GH, Singh S and Aggarwal BB: Hydrogen peroxide
activates NF-kappa B through tyrosine phosphorylation of I kappa B
alpha and serine phosphorylation of p65: evidence for the
involvement of I kappa B alpha kinase and Syk protein-tyrosine
kinase. J Biol Chem. 278:24233–24241. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Kretz-Remy C, Mehlen P, Mirault ME and
Arrigo AP: Inhibition of I kappa B-alpha phosphorylation and
degradation and subsequent NF-kappa B activation by glutathione
peroxidase overexpression. J Cell Biol. 133:1083–1093. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Schreck R, Rieber P and Baeuerle PA:
Reactive oxygen intermediates as apparently widely used messengers
in the activation of the NF-kappa B transcription factor and HIV-1.
EMBO J. 10:2247–2258. 1991.PubMed/NCBI
|
|
52
|
Arlt A, Vorndamm J, Breitenbroich M,
Fölsch UR, Kalthoff H, Schmidt WE and Schäfer H: Inhibition of
NF-kappa B sensitizes human pancreatic carcinoma cells to apoptosis
induced by etoposide (VP16) or doxorubicin. Oncogene. 20:859–868.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang S, Kotamraju S, Konorev E, Kalivendi
S, Joseph J and Kalyanaraman B: Activation of nuclear factor-kappaB
during doxorubicin-induced apoptosis in endothelial cells and
myocytes is pro-apoptotic: The role of hydrogen peroxide. Biochem
J. 367:729–740. 2002. View Article : Google Scholar : PubMed/NCBI
|
